Skip to main content

Moderna, Inc.

MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001682852

In the last 90 days, Moderna, Inc. insiders filed 0 open-market purchases and 5 sales; 784 institutions reported holding it in 13F filings for Q2 2026, worth $22.3B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Moderna, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
5 filings
4 insiders, $49.2M in total
Insiders trading
4
Net value
−$49.2M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Moderna, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Moderna, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Hoge StephenPresident1,562,029Sep 16, 202613
Mock James MChief Financial Officer59,375Sep 14, 202616
Klinger Shannon ThymeChief Legal Officer81,340Sep 8, 202612
Bancel StephaneChief Executive Officer6,440,260Aug 7, 20264
McDonnell Michael RDirector–Jul 10, 20261
Banque Soria EsterChief Commercial Officer–Jul 7, 20261
Afeyan NoubarDirector3,924IndirectMay 22, 20263
Tallett Elizabeth EDirector4,761May 8, 20262
Nader FrancoisDirector32,781May 8, 20262
Rubenstein David M.Director9,643May 8, 20262
Nabel Elizabeth GDirector19,317May 8, 20262
Horning SandraDirector18,585May 8, 20262
Hussain AbbasDirector12,066May 8, 20264
Sagan PaulDirector312,027IndirectMay 1, 20250
Langer RobertDirector11,467,664May 7, 20240
Berenson StephenDirector22,203May 7, 20240
Garay ArpaChief Commercial Officer3,690Dec 7, 20230
Andres JuanSee remarks12,803Dec 30, 20220
Burton PaulChief Medical Officer954Nov 8, 20220
Meline David WChief Financial Officer2,857Aug 11, 20220
Zaks Tal ZviChief Medical Officer0Jul 2, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 31, 2024 (view filing)May 292 daysAfeyan NoubarDirectorSSale−20.0K$145.08−$2.90M−1.0%1.96M after8 lots10b5-1
May 30, 2024 (view filing)May 291 dayMock James MChief Financial OfficerSSale−183$144.50−$26.4K−3.0%5.87K after10b5-1
May 30, 2024 (view filing)May 291 dayKlinger Shannon ThymeChief Legal OfficerSSale−183$144.50−$26.4K−1.7%10.8K after10b5-1
May 30, 2024 (view filing)May 291 dayHoge StephenPresidentSSale−341$144.50−$49.3K0.0%1.47M after10b5-1
May 29, 2024 (view filing)May 281 dayMock James MChief Financial OfficerSSale−648$162.47−$105.3K−10.2%5.73K after10b5-1
May 29, 2024 (view filing)May 281 dayKlinger Shannon ThymeChief Legal OfficerSSale−1.30K$162.47−$210.6K−10.9%10.6K after10b5-1
May 24, 2024 (view filing)May 222 daysAfeyan NoubarDirectorSSale−15.0K$157.57−$2.36M−0.8%1.98M after19 lots10b5-1
May 17, 2024 (view filing)May 152 daysHoge StephenPresidentSSale−15.0K$127.49−$1.91M−1.0%1.47M after10b5-1
May 17, 2024 (view filing)May 152 daysAfeyan NoubarDirectorSSale−15.0K$127.33−$1.91M−0.7%2.00M after5 lots10b5-1
May 13, 2024 (view filing)May 103 daysHoge StephenPresidentSSale−255$120.96−$30.8K0.0%1.49M after10b5-1
May 10, 2024 (view filing)May 82 daysAfeyan NoubarDirectorSSale−15.0K$121.68−$1.83M−0.7%2.01M after3 lots10b5-1
May 3, 2024 (view filing)May 12 daysAfeyan NoubarDirectorSSale−15.0K$110.92−$1.66M−0.7%2.03M after5 lots10b5-1
Apr 26, 2024 (view filing)Apr 242 daysAfeyan NoubarDirectorSSale−15.0K$108.32−$1.62M−0.7%2.04M after4 lots10b5-1
Apr 19, 2024 (view filing)Apr 172 daysAfeyan NoubarDirectorSSale−15.0K$103.38−$1.55M−0.7%2.06M after3 lots10b5-1
Apr 16, 2024 (view filing)Apr 151 dayHoge StephenPresidentSSale−15.0K$105.02−$1.58M−1.0%1.49M after10b5-1
Apr 12, 2024 (view filing)Apr 102 daysAfeyan NoubarDirectorSSale−15.0K$107.12−$1.61M−0.7%2.07M after4 lots10b5-1
Apr 9, 2024 (view filing)Apr 81 dayMock James MChief Financial OfficerSSale−705$101.93−$71.9K−12.3%5.05K after10b5-1
Apr 5, 2024 (view filing)Apr 32 daysAfeyan NoubarDirectorSSale−15.0K$101.68−$1.53M−0.7%2.09M after7 lots10b5-1
Mar 29, 2024 (view filing)Mar 272 daysAfeyan NoubarDirectorSSale−15.0K$109.06−$1.64M−0.7%2.10M after6 lots10b5-1
Mar 22, 2024 (view filing)Mar 202 daysAfeyan NoubarDirectorSSale−15.0K$102.39−$1.54M−0.7%2.12M after3 lots10b5-1
Mar 19, 2024 (view filing)Mar 154 daysHoge StephenPresidentSSale−15.0K$103.17−$1.55M−1.0%1.50M after10b5-1
Mar 15, 2024 (view filing)Mar 132 daysAfeyan NoubarDirectorSSale−15.0K$108.54−$1.63M−0.7%2.13M after7 lots10b5-1
Mar 11, 2024 (view filing)Mar 83 daysKlinger Shannon ThymeChief Legal OfficerSSale−544$99.05−$53.9K−5.5%9.27K after10b5-1
Mar 5, 2024 (view filing)Mar 41 dayKlinger Shannon ThymeChief Legal OfficerSSale−117$94.34−$11.0K−1.3%8.67K after10b5-1
Mar 5, 2024 (view filing)Mar 41 dayHoge StephenPresidentSSale−309$94.34−$29.2K0.0%1.52M after10b5-1
Mar 1, 2024 (view filing)Feb 291 dayMock James MChief Financial OfficerSSale−647$94.57−$61.2K−13.1%4.30K after10b5-1
Mar 1, 2024 (view filing)Feb 291 dayKlinger Shannon ThymeChief Legal OfficerSSale−670$94.57−$63.4K−7.3%8.56K after10b5-1
Mar 1, 2024 (view filing)Feb 291 dayHoge StephenPresidentSSale−2.39K$94.57−$225.8K−0.2%1.52M after10b5-1
Feb 23, 2024 (view filing)Feb 221 dayHoge StephenPresidentSSale−15.0K$100.00−$1.50M−1.0%1.51M after10b5-1
Feb 16, 2024 (view filing)Feb 16Same dayHoge StephenPresidentSSale−10.5K$88.88−$937.0K−0.7%1.53M after10b5-1
Feb 16, 2024 (view filing)Feb 16Same dayBancel StephaneChief Executive OfficerSSale−26.4K$88.88−$2.34M−0.5%5.46M after10b5-1
Feb 13, 2024 (view filing)Feb 121 dayHoge StephenPresidentSSale−304$86.23−$26.2K0.0%1.52M after10b5-1
Jan 17, 2024 (view filing)Jan 161 dayHoge StephenPresidentSSale−15.0K$103.90−$1.56M−1.0%1.52M after10b5-1
Jan 9, 2024 (view filing)Jan 81 dayMock James MChief Financial OfficerSSale−772$109.75−$84.7K−17.5%3.63K after10b5-1
Dec 28, 2023 (view filing)Dec 271 dayHoge StephenPresidentSSale−45.0K$100.01−$4.50M−2.9%1.53M after10b5-1
Dec 11, 2023 (view filing)Dec 83 daysKlinger Shannon ThymeChief Legal OfficerSSale−563$79.09−$44.5K−6.6%7.91K after10b5-1
Dec 7, 2023 (view filing)Dec 61 dayGaray ArpaChief Commercial OfficerSSale−564$78.34−$44.2K−13.3%3.69K after10b5-1
Dec 5, 2023 (view filing)Dec 41 dayKlinger Shannon ThymeChief Legal OfficerSSale−111$79.31−$8.80K−1.5%7.34K after10b5-1
Dec 5, 2023 (view filing)Dec 41 dayHoge StephenPresidentSSale−309$79.31−$24.5K0.0%1.58M after10b5-1
Nov 30, 2023 (view filing)Nov 291 dayHoge StephenPresidentSSale−1.14K$79.81−$90.7K−0.1%1.58M after10b5-1
Nov 13, 2023 (view filing)Nov 103 daysHoge StephenPresidentSSale−263$68.76−$18.1K0.0%1.57M after10b5-1
Nov 3, 2023 (view filing)Nov 12 daysAfeyan NoubarDirectorSSale−10.0K$76.00−$760.0K−0.5%2.15M after2 lots10b5-1
Oct 27, 2023 (view filing)Oct 252 daysAfeyan NoubarDirectorSSale−10.0K$76.99−$769.9K−0.5%2.16M after3 lots10b5-1
Oct 13, 2023 (view filing)Oct 112 daysAfeyan NoubarDirectorSSale−15.0K$103.30−$1.55M−0.7%2.17M after4 lots10b5-1
Oct 10, 2023 (view filing)Oct 64 daysMock James MChief Financial OfficerSSale−2.86K$102.50−$292.9K−49.2%2.95K after10b5-1
Oct 6, 2023 (view filing)Oct 42 daysAfeyan NoubarDirectorSSale−15.0K$102.72−$1.54M−0.7%2.18M after5 lots10b5-1
Sep 29, 2023 (view filing)Sep 272 daysAfeyan NoubarDirectorSSale−10.0K$98.97−$989.7K−0.5%2.20M after3 lots10b5-1
Sep 22, 2023 (view filing)Sep 202 daysAfeyan NoubarDirectorSSale−15.0K$104.74−$1.57M−0.7%2.21M after3 lots10b5-1
Sep 18, 2023 (view filing)Sep 153 daysHoge StephenPresidentSSale−15.0K$112.99−$1.69M−0.9%1.57M after10b5-1
Sep 15, 2023 (view filing)Sep 132 daysAfeyan NoubarDirectorSSale−15.0K$109.70−$1.65M−0.7%2.22M after7 lots10b5-1